One of the most recent studies on TF in cancer—specifically, pancreatic cancer—by the Flick laboratory reported that TF promotes PDAC progression through thrombin generation and the subsequent activation of protease-activate receptor 1 (PAR-1), a member of a G-protein coupled receptor subfamily [17]. Here, F2R is linked to pancreatic neoplasm.